Holen Sie sich die Stockscreener-App
1.09
1.80%
-0.02
Schlusskurs vom Vortag:
$1.11
Offen:
$1.13
24-Stunden-Volumen:
67,933
Relative Volume:
0.15
Marktkapitalisierung:
$154.13M
Einnahmen:
Nettoeinkommen (Verlust:
KGV:
-
EPS:
-
Netto-Cashflow:
1W Leistung:
+0.00%
1M Leistung:
-28.29%
6M Leistung:
+0.00%
1J Leistung:
+0.00%
1-Tages-Spanne:
$1.06
$1.13
1-Wochen-Bereich:
$1.07
$1.4089
52-Wochen-Spanne:
$1.04
$27.36
Veraxa Biotech Ag Stock (VRXA) Company Profile
Firmenname
Veraxa Biotech Ag
Sektor
Branche
Telefon
-
Adresse
-
Compare VRXA vs VRTX, MRNA, REGN, ARGX, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
VRXA
Veraxa Biotech Ag
|
1.09 | 154.13M | 0 | 0 | 0 | 0.00 |
VRTX
Vertex Pharmaceuticals Inc
|
508.15 | 128.80B | 12.34B | 4.34B | 3.71B | 16.87 |
MRNA
Moderna Inc
|
238.82 | 95.35B | 2.23B | -3.19B | -1.60B | -8.1462 |
REGN
Regeneron Pharmaceuticals Inc
|
799.63 | 82.33B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
851.39 | 53.54B | 4.16B | 1.29B | 734.26M | 19.58 |
ONC
Beone Medicines Ltd Adr
|
373.90 | 42.30B | 5.76B | 514.49M | 1.10B | 4.4813 |
Veraxa Biotech Ag Aktie (VRXA) Neueste Nachrichten
VERAXA Biotech Provides Overview on Implementation of FDA-Aligned Human-Relevant Models into R&D Strategy - GlobeNewswire Inc.
Veraxa Biotech AG (VRXA) Stock Price & News - Syfe
Form 4 Veraxa Biotech AG For: 29 September By Investing.com - Investing.com Nigeria
Form 4 Veraxa Biotech AG For: 29 September By Investing.com - Investing.com UK
LAWR Stock Price, Quote & News - Syfe
DSWL Stock Price, Quote & News - Syfe
Veraxa Biotech (VRXA) CFO named insider with no reported shares - Stock Titan
Veraxa Biotech AG Stock Price: VRXA Stock Chart, Market Cap & News Today - CoinGecko
VERAXA Biotech Appoints Dr. Christoph Erkel as CSO to Steer BiTAC® Toward Clinical Trials - citybuzz -
VERAXA Biotech Designates Raju Willener as CFO - Yahoo Finance
VERAXA Biotech (NASDAQ: VRXA) Appoints Raju Willener As Chief Financial Officer - Menafn
Veraxa Biotech AG (NASDAQ: VRXA) Revises Prospectus for Up to 120.3 Million Shares and Warrants - Kalkine Media
Veraxa Biotech AG (NASDAQ: VRXA) Names Raju Willener as CFO Following De-SPAC Completion - Kalkine Media
VERAXA Biotech (VRXA) Appoints Raju Willener as Chief Financial Officer - Yahoo Finance
Veraxa Biotech (VRXA) Insider Trading Activity 2026 - marketbeat.com
VERAXA Biotech (NASDAQ: VRXA) Appoints Raju Willener as Chief Financial Officer - TradingView
VRXA Rises As Veraxa Biotech AG Draws Trader Focus - timothysykes.com
Veraxa Biotech AG Company Profile & Introduction - Moomoo
VRXA Jumps As Traders Focus On Biotech Breakout Setup - timothysykes.com
VERAXA Biotech Appoints Veteran Finance Executive Raju Willener as CFO to Drive Capital Strategy and Oncology Pipeline Growth - citybuzz -
Veraxa Biotech AG (VRXA) Stock Price | Live Quotes & Charts | NASDAQ - timothysykes.com
Veraxa Biotech names Raju Willener as chief financial officer By Investing.com - Investing.com Australia
Veraxa Biotech AG Announces Chief Financial Officer Changes - marketscreener.com
Veraxa Biotech stock rises after naming Raju Willener as CFO By Investing.com - Investing.com India
Veraxa Biotech stock rises after naming Raju Willener as CFO By Investing.com - Investing.com South Africa
Veraxa Biotech stock rises after naming Raju Willener as CFO By Investing.com - Investing.com Australia
Veraxa Biotech stock rises after naming Raju Willener as CFO By Investing.com - Investing.com Canada
Veraxa Biotech stock rises after naming Raju Willener as CFO By Investing.com - Investing.com Nigeria
Veraxa Biotech stock rises after naming Raju Willener as CFO - investing.com
Veraxa Biotech names Raju Willener as chief financial officer By Investing.com - Investing.com South Africa
Finance veteran behind CHF 30B portfolios joins Veraxa Biotech (VRXA) as CFO - Stock Titan
Veraxa Biotech names Raju Willener as chief financial officer By Investing.com - Investing.com Canada
Veraxa Biotech names Raju Willener as chief financial officer By Investing.com - Investing.com Nigeria
Veraxa Biotech names Raju Willener as chief financial officer - Investing.com
Veraxa Biotech names Raju Willener as chief financial officer By Investing.com - Investing.com India
VERAXA Biotech Appoints Raju Willener as Chief Financial Officer - kommunikasjon.ntb.no
Insider Buys Additional CHF75k In Veraxa Biotech Stock - simplywall.st
Veraxa Biotech AG Company Profile & Introduction - Moomoo
Veraxa Biotech (VRXA) 10K Form and Latest SEC Filings 2026 - MarketBeat
Veraxa Biotech (VRXA) Stock Price, News & Analysis - marketbeat.com
Veraxa Biotech (VRXA) Stock Chart and Price History 2026 - marketbeat.com
Veraxa Biotech (VRXA) director adds 50K shares in open-market buy - Stock Titan
Veraxa Biotech (VRXA) CEO now holds 5,000 ordinary shares - Stock Titan
VERAXA Biotech (NASDAQ: VRXA), Secarna Partnership Milestone Opens New Potential Market for Conjugation T - Benzinga
Early lab data advance Veraxa (Nasdaq: VRXA) autoimmune AOC - stocktitan.net
Veraxa and Secarna report positive early results from AOC study By Investing.com - Investing.com India
Veraxa Biotech AG - Via Ritzau
VERAXA Biotech and Secarna Pharmaceuticals Achieve Research Milestone in Antibody Oligonucleotide Conjugate (AOC) Alliance - The Manila Times
VERAXA Biotech AG: Valuation Ratios, Analysts' Forecasts - marketscreener.com
Veraxa Biotech (VRXA) interim CFO discloses zero share ownership - Stock Titan
Finanzdaten der Veraxa Biotech Ag-Aktie (VRXA)
Es liegen keine Finanzdaten für Veraxa Biotech Ag (VRXA) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
Veraxa Biotech Ag-Aktie (VRXA) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Antz Christoph Rudiger | Chief Executive Officer |
Aug 27 '26 |
Buy |
1.53 |
5,000 |
7,650 |
5,000 |
0.20%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):